C12Y 101/01283
Methylglyoxal reductase
Official title: Methylglyoxal reductase (NADPH-dependent) (1.1.1.283)
C12Y101/01283 (Methylglyoxal reductase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 5
- Inventors
- 14
- Latest grant
- 12 Jan 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of molecules by periplasmic enzymatic catalysis7 May 2026US 2026/0125713 A1Bioc3
- Methods and compositions for efficient production of biofuels and bioplastics from toxic feedstocks29 Aug 2024US 2024/0287549 A1Massachusetts Institute of Technology
- Conversion of methylglyoxal into hydroxyacetone using novel enzymes and applications thereof11 Jun 2020US 2020/0181652 A1Metabolic Explorer
- Methods and materials for the biosynthesis of diol alcohols and related compounds1 Aug 2019US 2019/0233848 A1Invista North America S A R L
- New lactaldehyde reductases for the production of 1,2-propanediol4 Oct 2018US 2018/0282706 A1Metabolic Explorer
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.